Merck ‘Does No Wrong’ but Pays $100M in NuvaRing Suit

Holy Hormones Journal:    Merck denies any wrongdoing – and yet a young woman is dead and from a double pulmonary embolism and thousands of others have filed law suits.

There have bee over 140 deaths and more than 32,000 adverse reactions to the HPV vaccine Gardasil*and Merck denies any nuvaringwrongdoing.

Vioxx, another Merck fiasco was pulled off the market and “… the recall raised serious ethical questions about whether Merck inappropriately downplayed Vioxx safety issues over the past several years.” Over 60,000 people died after taking Vioxx.

These are serious allegations and yet Merck had over $47 billion in sales in 2012 – drops $100 mil on the table and walks away.  What about the potential risk of death and adverse reaction to other girls who are on the NuvaRing?

I found this great line in a very intriguing article about Merck, the FDA and trialling new drugs. The article entitled: The Big Sleep by Ian Parker in The New Yorker (Dec. 2013):

 How successfully can a pharmaceutical giant—through advertising and sales visits to doctors’ offices—sell a drug at a dose that has been repeatedly described as ineffective by the scientists who developed it?

The kicker is Merck is doing the study.
I think their answer is pretty clear.

*As reported to VAERS the Vaccine Adverse Event Reporting System; with only an estimated 1 to 10%  of HPV vaccine injured girls reporting.

NuvaRing Manufacturer Merck Settles for $100 million

Vanity Fair
Mickey Stanley
February 7, 2014

Merck, the pharmaceutical giant, agreed this morning to settle for $100 million with the thousands of claimants who have filed suit against their profitable contraceptive, NuvaRing. As Marie Brenner discussed in her January article, claimants have alleged that Merck wanuvaring-health-death-danger-scandal crops not forthcoming enough about the drug’s side effects, including potentially fatal blood clots. Merck denied any wrongdoing under the agreement preliminarily approved by a judge and pending the participation of 95 percent of the plaintiffs. Their competitor, Bayer, has already paid out $1.6 billion over the last two years to claimants against their contraceptive drugs, Yaz and Yasmin, over blood-clot related issues.

Rick and Karen Langhart—the Colorado couple whom Brenner profiled in her January article—have been battling Merck ever since their 24-year-old daughter, Erika, died of a double pulmonary embolism in 2011 while using NuvaRing. “We are absolutely devastated,” said Karen Langhart of the settlement figure. “This is exactly what we have feared.”


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.